Innovation and Research

Changing the bacteria in the gut can help patients with advanced melanoma, according to a Pitt-UPMC study published in Science.

As labs have shifted attention to SARS-CoV-2, efforts have been duplicated and precious time and resources have been used ineffectively, writes Terence Dermody for The Conversation and Knowable Magazine.

The University of Pittsburgh joins 21 other leading academic and research institutions in the Leap Breakthrough Network. Its charge? Spark breakthrough scientific and technological solutions in human physiology and bioengineering within a decade.

Early results of the trial, which is part of a three-trial platform consortium spanning more than 300 hospitals worldwide, found that full doses of heparin, a blood thinner, were not only safe but also reduced the need for vital organ support, such as ventilation.

As the Biden-Harris presidential transition begins, Pitt experts share their thoughts on racial justice, immigration and other significant issues that face the incoming administration.

Fueled by a grant from the Richard King Mellon Foundation, researchers in Pitt’s Center for Research on Behavioral Health, Media and Technology are studying and combating false online information about vaccines.

Telehealth visits to help veterans access and adjust technology such as wheelchairs were just as effective as in-person visits, studies from Pitt’s Human Engineering Research Laboratories found.

Almost by accident, Pittsburgh police officer Antonio Ruiz joined the Moderna vaccine trial at Pitt. Read how his experience played out.

The University today announced a collaboration with the U.S. Food and Drug Administration’s Center for Devices and Radiological Health to help address the needs of the visually impaired.

For The Conversation, Randy P. Juhl, Pitt Dean Emeritus and Distinguished Service Professor Emeritus of Pharmacy, wrote about what it takes to change behavior due to health risks—and what it means for the COVID-19 pandemic.